NFKB1 and neoplasm: Since NF-kB was found to be downstream of Dll1-mediated Notch signaling, we next sought to determine if the NF-kB inhibitor IMD-0354 (IMD) would resensitize tumor cells to chemotherapy, phenocopying the effect of the Dll1-blocking antibody.